By Admin at 8 Feb 2016
Not all cancer patients are candidates for chemo alternatives, but some, like those with chronic lymphocytic leukemia (CLL), may fare better by skipping chemo and instead taking anti-cancer drugs.
By Admin at 23 Oct 2015
Chronic lymphocytic leukemia (CLL) is the most common type of leukemia in adults, and although survival rates vary from two to 20 years after diagnosis, it is considered incurable with conventional therapies. While stem cell transplants may provide a cure, not all patients are eligible for the procedure, which is why a new experimental therapy, called CTL019, is raising hope for many.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial